Indian Pharmaceuticals & Biotech Potentially Undervalued Small Caps

Haleos Labs

Market Cap: ₹3.9b

Engages in the manufacturing of active pharmaceutical ingredients (API) and intermediates in India.

Tyche Industries

Market Cap: ₹1.3b

Manufactures and sells active pharmaceutical ingredients and intermediates in India and internationally.

Cian Healthcare

Market Cap: ₹206.5m

Engages in the research, development, manufacture, marketing, and sale of pharmaceutical products in India.

Coral Laboratories

Market Cap: ₹1.5b

Manufactures and sells pharmaceutical formulations in India, Ethiopia, and internationally.

Fabino Enterprises

Market Cap: ₹40.6m

Manufactures, markets, trades, and packages pharmaceutical and other wellness focused consumer products in India.

Par Drugs and Chemicals

Market Cap: ₹1.1b

Develops, manufactures, and sells active pharmaceutical ingredients (APIs) and fine chemicals in India.

Gujarat Terce Laboratories

Market Cap: ₹242.7m

Develops, manufactures, markets, and distributes medicines and healthcare products in India and internationally.

Bilcare

Market Cap: ₹1.5b

Provides pharmaceutical packaging research solutions in India and internationally.

Nectar Lifesciences

Market Cap: ₹2.3b

Manufactures, distributes, markets and sells pharmaceutical products in India and internationally.

Sunil Healthcare

Market Cap: ₹631.5m

Engages in the manufacture and sale of empty hard gelatin, hydroxypropyl methylcellulose (HPMC), and pullulan capsules shells in India and internationally.